4 A large 2025 scoping review identified hair loss as an "emerging" adverse effect worth systematic investigation, noting that most existing studies lack formal dermatologic diagnostic confirmation, meaning real-world prevalence is likely underreported
For diabetes management, if HbA1c remains above target despite maximal tirzepatide dosing, combination therapy with metformin, SGLT2 inhibitors, or basal insulin should be considered based on individual patient factors and contraindications
Despite the growing evidence for cardiorenal benefits of GLP-1 medicines, the precise mechanisms underlying these benefits remain incompletely understood
Semaglutide has a longer half-life (about 7 days) so the washout effectively means missing one or two doses before retatrutide initiation
SOAP Notes for Social Work covers effective clinical note-writing for case managers and behavioral health providers
GLP-1 Agonists: Transforming Diabetes & Weight Management From glucose control to significant weight loss, GLP-1 receptor agonists are redefining how we approach metabolic diseases